PlainRecalls
FDA Drug Low Class III Terminated

Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03

Reported: October 1, 2014 Initiated: April 18, 2014 #D-1609-2014

Product Description

Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03

Reason for Recall

Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.

Details

Recalling Firm
Apotex Corp.
Units Affected
5,397 bottles
Distribution
Nationwide.
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03. Recalled by Apotex Corp.. Units affected: 5,397 bottles.
Why was this product recalled?
Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 1, 2014. Severity: Low. Recall number: D-1609-2014.